ArticleClinical and translational radiation oncology2021

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients.

Marieke van Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.